The new subsidiary of nonprofit generic drug maker Civica Rx and backed by Blue Cross and Blue Shield plans is poised to go after prescriptions that are generic yet have little competition and high prices like insulin.
High Insulin Prices May Be First Remedy For New Blue Cross Drug Maker
